BDNF: Discontinued Phase II trials

Regeneron Pharmaceuticals Inc. (REGN), Tarrytown, N.Y. Product: BDNF Therapeutic category: Hormone Target: BDNF receptors on motor neurons Description: Brain derived neurotrophic factor Indication: ...